Boston Scientific Corporation (NYSE: BSX) will participate in the BMO Capital Markets Prescriptions for Success Healthcare Conference on December 14, 2017 in New York. Susie Lisa, vice president,...

Moffitt Cancer Center announced that last week it treated the first patient commercially in the United States with the recently Food and Drug Administration-approved Yescarta™, a Chimeric...

CECO Environmental Corp. (Nasdaq: CECE), today announced that Dennis Sadlowski, Chief Executive Officer, and Matt Eckl, Chief Financial Officer, will participate at the 5th Annual ROTH Industrial...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today revealed several technology innovations to further optimize the entire medication management...

Bayer and Loxo Oncology, Inc., (NASDAQ: LOXO), today announced updated clinical data from the larotrectinib (LOXO-101) pediatric Phase I SCOUT trial (NCT02637687). These data are being presented...